Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19
NCT04373135
Attitude of Health Personnel, Attitude to Health
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT04401254
Patients who are critically ill with COVID-19 requiring life support in an intensive care unit (ICU) have increased risk of morbidity and mortality. Currently the ICU community does not know what effect the disease, the ICU admission, physiotherapy interventions and life support have on their long-term quality of life and whether they can return to their pre-illness level of function following ICU.
COVID-Recovery will describe the physiotherapy interventions delivered to critically ill patients with COVID-19. In survivors, COVID-Recovery will utilise telephone follow-up of ICU survivors to assess disability-free survival and quality of life at 6 months after ICU admission. Additionally, COVID-Recovery will identify if there are predictors of disability-free survival. COVID-Recovery will aim to select up to 300 patients diagnosed with COVID-19 from ICUs in Australia. If they survive to hospital discharge, patients will be invited to receive a telephone questionnaire at 6 months after the ICU admission that aims to assess their long-term outcomes, including physical, cognitive and emotional function, quality of life, and whether they have been able to return to work following ICU discharge.
To describe the experience of critical illness in survivors of COVID-19 and their family members.
To explore and describe functional recovery, respiratory system function and respiratory health morbidity up to 6 months after ICU admission in persistently critically ill adults with COVID-19
Looking for future studies?
Notify Me17 year and older
All sexes
Observational
Canberra Hospital, Garran, Australian Capital Territory, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Persistent critical illness cohort
Exclusion criteria
Time frame: 6 months
a composite measure of WHODAS 2.0 - 12 level and hospital survival
Time frame: During the ICU stay until 3 months
The physiotherapy interventions provided to patients with COVID-19 admitted to the ICU and health outcomes
Time frame: 6 months
Health related quality of life measured with EQ5D-5L score from 0 to 100
Time frame: 6 months
World Health Organization Disability Assessment Schedule 2.0 12L
Time frame: 6 months
Montreal Cognitive Assessment Blind
Time frame: 6 months
Hospital Anxiety and Depression Scale
Time frame: 6 months
Impact of Events Scale Revised
Time frame: 6 months
WHODAS 2.0
Time frame: During the ICU stay until 28 days
Time frame: During the ICU stay until 28 days
Physiotherapist reported barriers to delivering the intervention
Time frame: During the ICU stay until 28 days
Adverse events that require the intervention to be ceased for medical intervention
Time frame: 6 months
Qualitative interviews
Time frame: 6 months
Global Rating of Change
Australian and New Zealand Intensive Care Research Centre
Other
The Coronavirus Disease 2019 - Recovery Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04373135
Attitude of Health Personnel, Attitude to Health
Los Angeles, California, United States
View Trial DetailsNCT04359914
Brain Diseases, COVID-19
Rostock, Mecklenburg-Vorpommern, Germany
View Trial DetailsNCT05963958
COVID-19, Confusion
João Pessoa, Paraíba, Brazil
View Trial DetailsNCT05224388
Anticoagulants and Bleeding Disorders, COVID-19
Ghent, Belgium
View Trial Details